Efficacy and safety of rh-endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh-endostatin plus pemetrexed maintenance in non-small cell lung cancer: A retrospective comparison with standard chemotherapy.

Thorac Cancer · 2018 · PMC6209785 · PMID 30152052

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

17 , 18 , 19 , 20 Despite the lack of significant differences, our results showed a trend of prolonged PFS and OS in the overall population, regardless of the addition of maintenance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.